Using artificial intelligence to improve the safety and quality of adaptive radiotherapy for cancer treatment
Artificial Intelligence-Based Quality Assurance for Online Adaptive Radiotherapy
['FUNDING_R01'] · UT SOUTHWESTERN MEDICAL CENTER · NIH-11034044
This study is looking at how using artificial intelligence with advanced MRI technology can make cancer treatment safer and more tailored to each patient by better tracking changes in their body during radiotherapy.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UT SOUTHWESTERN MEDICAL CENTER (nih funded) |
| Locations | 1 site (DALLAS, UNITED STATES) |
| Trial ID | NIH-11034044 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the quality assurance processes in adaptive radiotherapy using artificial intelligence (AI). By integrating AI with MR-LINAC technology, which combines advanced radiotherapy with MRI imaging, the project aims to create a more efficient and accurate method for monitoring and adjusting treatment plans based on daily anatomical changes in cancer patients. The goal is to reduce the risk of errors during treatment and improve overall patient safety and treatment effectiveness. Patients undergoing radiotherapy will benefit from a more personalized and precise approach to their care.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing adaptive radiotherapy for advanced cancer.
Not a fit: Patients who are not receiving radiotherapy or those with early-stage cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective cancer treatments through improved quality assurance in radiotherapy.
How similar studies have performed: Other research has shown promising results in using AI for quality assurance in medical treatments, indicating a strong potential for success in this novel application.
Where this research is happening
DALLAS, UNITED STATES
- UT SOUTHWESTERN MEDICAL CENTER — DALLAS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: JIANG, STEVE BIN — UT SOUTHWESTERN MEDICAL CENTER
- Study coordinator: JIANG, STEVE BIN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Advanced Cancer